nameDr. Mark Strobeck
roleCEO
linkedin none on file
contactnot published
filingsnone on file
quotes
As I described in our third quarter 2022 conference call, we believe that Rockwell Medical has a robust business which has been historically compromised by a number of factors, including but not limited to restrictive and disadvantageous contracts, mounting expenses, and competing priorities.
Aug 14, 2023 / CEO / receipt, needs a key / Dr. Mark Strobeck, CEO | earnings call 2023-08-14 | transcript cf45c736-69d1-4cd8-94c5-304570d1d82b | chars 4019-4312 | segment 4
steadybase-$